Olivier Brandicourt is a director of Alnylam Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Feb 24 | BGNE BeiGene | Share Option Ordinary Shares | Grant | Acquire A | No | No | 12.74 | 27,794 | 354.10 k | 27,794 |
18 May 23 | ALNY Alnylam Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 189.87 | 3,454 | 655.81 k | 3,454 |